Acute Ischemic Stroke Therapeutics Global Market Report 2024: Exploring Growth, Trends, and Projections

The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only!

LONDON, GREATER LONDON, UNITED KINGDOM, December 5, 2024 /EINPresswire.com/ --
The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!

What Growth can the Acute Ischemic Stroke Therapeutics Market Expect?
With robust growth in recent years, the acute ischemic stroke therapeutics market continues to expand in size. Growth from $8.47 billion in 2023 to an estimated $9.24 billion in 2024 is anticipated, indicating a compound annual growth rate CAGR of 9.0%. Factors contributing to this growth include an increasing number of patients, surge in the geriatric population, growing obesity prevalence, increasing ischemic stroke cases, and a rise in hypertension.

For an in-depth analysis of the acute ischemic stroke therapeutics market, request a sample report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19265&type=smp

What Future Growth is Projected for the Acute Ischemic Stroke Therapeutics Market?
Looking ahead, the acute ischemic stroke therapeutics market size is forecasted to enjoy strong growth, rising to $13.17 billion in 2028 at a CAGR of 9.3%. Driving this predicted growth are an increase in preference for online pharmacies, rise in cardiovascular diseases, growing cholesterol levels, and greater occurrence of diseases and ischemic stroke. At the same time, major advancements in medical technology, the incorporation of artificial intelligence and machine learning, developments in neurology, and the uptake of technologically advanced diagnostics will further shape market trends.

What are the Market Drivers for Acute Ischemic Stroke Therapeutics?
Hypertension, in particular, is seen as a significant factor propelling the growth of the acute ischemic stroke therapeutics market going forward. Hypertension, also known as high blood pressure, elevates the force of blood against artery walls which in turn heightens the risk of heart disease, stroke, and other health disorders. Hypertension prevalence is driven primarily by an aging population and escalating obesity rates. To manage hypertension, acute ischemic stroke therapeutics address complications arising from stroke and prevent further damage to cerebrovascular functions, which are often linked to high blood pressure.

Reserve your copy of the full report:
https://www.thebusinessresearchcompany.com/report/acute-ischemic-stroke-therapeutics-global-market-report

Who are the Key Players in the Acute Ischemic Stroke Therapeutics Market?
Johnson & Johnson, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Medtronic plc, Eli Lilly and Company, Amgen Inc., Stryker Corporation, Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Otsuka Pharmaceutical Co. Ltd., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Genentech Inc., NoNO Inc., Athersys Inc., and XBiotech Inc., ZZ Biotech LLC are among the major players operating within the acute ischemic stroke therapeutics market.

What are the Emerging Trends in the Acute Ischemic Stroke Therapeutics Market?
Advancements in medical technologies via innovative solutions such as exosome-based therapy for neurological indications are key areas of focus. Emerging players like Aruna Bio have entered the path to enhancing treatment efficacy and improving patient outcomes through this novel approach in treating acute ischemic stroke patients in the 2024 trial with its proprietary neural exosomes.

Which Segments form the Acute Ischemic Stroke Therapeutics Market?
The acute ischemic stroke therapeutics market covered in this report is segmented –

1 By Type: Thrombolytic Therapeutics, Antihypertensive Therapeutics, Antiplatelet Therapeutics, Anticoagulants
2 By Route Of Administration: Oral, Parenteral
3 By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4 By Application: Hospitals, Ambulatory Surgical Center, Diagnostic Centers

What are the Regional Insights on the Acute Ischemic Stroke Therapeutics Market?
In 2023, North America was the largest region in the acute ischemic stroke therapeutics market. Meanwhile, Asia-Pacific is projected to be the fastest-growing region. Regions addressed in this report include, but are not limited to, Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:
Acute Intermittent Porphyria Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/acute-intermittent-porphyria-global-market-report
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report
Precision Medicine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Connect with us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Study more than 15000+ reports across 27 industries and 60+ geographies, drawing upon 1,500,000 datasets, extensive secondary research, and exclusive interviews with industry leaders from The Business Research Company—a known industry leader.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn